Literature DB >> 2168960

EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families.

J W Gratama1, M A Oosterveer, G Klein, I Ernberg.   

Abstract

The Epstein-Barr virus (EBV)-determined nuclear antigens EBNA 1, 2, 3, 4, and 6, regularly expressed in EBV-transformed lymphoblastoid cell lines, vary in size among viral strains. We have used this characteristic to trace the spread of the virus within seven families by using an approach called Ebnotyping. Among 33 evaluable individuals, 3 were EBV seronegative, and 17 different EBV strains could be isolated from the peripheral blood or throat washes of the remaining 30. All unrelated persons carried different strains. The EBV strain carried by 19 persons was also found in 1 or more family members. The same viral strain was carried by two members in five families, by three members in the sixth, and by five members in the seventh. The paternal strain was isolated from one child in two families, and the maternal strain was isolated from one or more children in three families. EBV was isolated from both blood and throat wash in six individuals. The Ebnotypes of both derived lymphoblastoid cell lines were identical within each individual. These results indicate that spread within families may be a relatively common route of EBV transmission. The number of horizontal transmission events required to generate diversification of the Ebnotype will require larger epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2168960      PMCID: PMC247956          DOI: 10.1128/JVI.64.10.4703-4708.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.

Authors:  J Finke; M Rowe; B Kallin; I Ernberg; A Rosén; J Dillner; G Klein
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.

Authors:  N Lewin; P Aman; M G Masucci; E Klein; G Klein; B Oberg; H Strander; W Henle; G Henle
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

3.  Epstein-Barr virus antibody in cases and contacts of infectious mononucleosis; a family study.

Authors:  F J Nye; H P Lambert
Journal:  J Hyg (Lond)       Date:  1973-03

4.  EBV antibodies in family contacts of patients with infectious mononucleosis.

Authors:  B Wahren; K Lantorp; G Sterner; A Espmark
Journal:  Proc Soc Exp Biol Med       Date:  1970-03

5.  Observations on childhood infections with the Epstein-Barr virus.

Authors:  G Henle; W Henle
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

6.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

7.  Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.

Authors:  I Ernberg; B Kallin; J Dillner; K Falk; B Ehlin-Henriksson; M L Hammarskjöld; G Klein
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

8.  Intrafamilial transmission of Epstein-Barr virus infections.

Authors:  G R Fleisher; P S Pasquariello; W S Warren; W S Zavod; A B Korval; H D Turner; E T Lennette
Journal:  J Pediatr       Date:  1981-01       Impact factor: 4.406

9.  Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines.

Authors:  N Lewin; P Aman; H Mellstedt; L Zech; G Klein
Journal:  Int J Cancer       Date:  1988-06-15       Impact factor: 7.396

10.  Fragment length polymorphisms among independent isolates of Epstein-Barr virus from immunocompromised and normal hosts.

Authors:  B Z Katz; J C Niederman; B A Olson; G Miller
Journal:  J Infect Dis       Date:  1988-02       Impact factor: 5.226

View more
  11 in total

1.  Epstein-Barr virus infection in allogeneic marrow grafting: lessons for transplant physicians and virologists.

Authors:  J W Gratama; M A Oosterveer; J Lepoutre; W E Fibbe; O Ringdén; J M Vossen; R Willemze; R L Bolhuis; J J van Rood; I Ernberg
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

2.  Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.

Authors:  Q Y Yao; D S Croom-Carter; R J Tierney; G Habeshaw; J T Wilde; F G Hill; C Conlon; A B Rickinson
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 3.  Detection and characterization of Epstein-Barr virus in clinical specimens.

Authors:  R F Ambinder; R B Mann
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.

Authors:  Q Y Yao; R J Tierney; D Croom-Carter; D Dukers; G M Cooper; C J Ellis; M Rowe; A B Rickinson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 5.  The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.

Authors:  Cindy M Chang; Kelly J Yu; Sam M Mbulaiteye; Allan Hildesheim; Kishor Bhatia
Journal:  Virus Res       Date:  2009-07-23       Impact factor: 3.303

6.  Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia.

Authors:  D M Walling; N Raab-Traub
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.

Authors:  D M Walling; A G Perkins; J Webster-Cyriaque; L Resnick; N Raab-Traub
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay.

Authors:  Diane Sitki-Green; Rachel H Edwards; Jennifer Webster-Cyriaque; Nancy Raab-Traub
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.

Authors:  Shizuko Harada; Yoshio Kamata; Yasuyuki Ishii; Hiroyuki Eda; Ryo Kitamura; Maya Obayashi; Sayuri Ito; Fumihiko Ban; Jun Kuranari; Haruhiko Nakajima; Tomoko Kuze; Masao Hayashi; Nobuhiko Okabe; Hidenobu Senpuku; Nobuyuki Miyasaka; Yoshiko Nakamura; Hirokazu Kanegane; Kazuo Yanagi
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

10.  Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers.

Authors:  Diane Sitki-Green; Mary Covington; Nancy Raab-Traub
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.